Maryland Charges Opioid Drugmaker With ‘Deceptive’ Scheme

BALTIMORE (AP) — Maryland authorities say an Arizona-based drugmaker engaged in a nationwide scheme characterized by “extraordinary misconduct” to boost profits amid the coast-to-coast opioid epidemic.
Attorney General Brian Frosh announced Thursday that his office filed charges against Insys Therapeutics alleging multiple violations of a consumer protect law.
Insys makes a highly addictive opioid spray used to manage pain for adult cancer patients. But Frosh says Insys joined